These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7717405)

  • 1. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.
    Szabó J; Heath B; Hill VM; Jackson CE; Zarbo RJ; Mallette LE; Chew SL; Besser GM; Thakker RV; Huff V
    Am J Hum Genet; 1995 Apr; 56(4):944-50. PubMed ID: 7717405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q.
    Hobbs MR; Pole AR; Pidwirny GN; Rosen IB; Zarbo RJ; Coon H; Heath H; Leppert M; Jackson CE
    Am J Hum Genet; 1999 Feb; 64(2):518-25. PubMed ID: 9973288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.
    Teh BT; Farnebo F; Kristoffersson U; Sundelin B; Cardinal J; Axelson R; Yap A; Epstein M; Heath H; Cameron D; Larsson C
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4204-11. PubMed ID: 8954016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.
    Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):191-6. PubMed ID: 10396361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred.
    Cavaco BM; Barros L; Pannett AA; Ruas L; Carvalheiro M; Ruas MM; Krausz T; Santos MA; Sobrinho LG; Leite V; Thakker RV
    QJM; 2001 Apr; 94(4):213-22. PubMed ID: 11294964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
    Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2114-20. PubMed ID: 9626148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
    Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1449-54. PubMed ID: 10770180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.
    Cavaco BM; Guerra L; Bradley KJ; Carvalho D; Harding B; Oliveira A; Santos MA; Sobrinho LG; Thakker RV; Leite V
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1747-52. PubMed ID: 15070940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
    Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome.
    Moon SD; Park JH; Kim EM; Kim JH; Han JH; Yoo SJ; Yoon KH; Kang MI; Lee KW; Son HY; Kang SK; Oh SJ; Kim KM; Yoon SJ; Park JG; Kim IJ; Kang HC; Hong SW; Kim KR; Cha BY
    J Clin Endocrinol Metab; 2005 Feb; 90(2):878-83. PubMed ID: 15613436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.
    Simonds WF; Robbins CM; Agarwal SK; Hendy GN; Carpten JD; Marx SJ
    J Clin Endocrinol Metab; 2004 Jan; 89(1):96-102. PubMed ID: 14715834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
    Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
    Nat Genet; 2002 Dec; 32(4):676-80. PubMed ID: 12434154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
    Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
    Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.